It’s hard to plan around Trump administration policies: One day, smartphones and other electronics are spared from tariffs; the next, the exemption is called temporary.
An EU tax on Meta could mean higher ad prices: The EU may take retaliatory measures against Trump’s tariffs that could shake up the advertising world.
Netflix’s AI search test takes aim at content fatigue: By letting users search more intuitively, Netflix hopes to edge out rivals and helps viewers navigate its library.
2025 could be another tough year for luxury companies: LVMH’s rough Q1 reveals considerable challenges as US spending drops.
On today’s podcast episode, we discuss how March Madness viewership stacked up this year, if women’s college basketball was able to sustain the bump from the ‘Caitlin Clark effect’, and how viewers of women’s sports are both different and the same. Join Senior Director of Podcasts and host Marcus Johnson, Analyst Paola Flores-Marquez, Vice President of Content Paul Verna, and Vice President of Inclusive Insights Charlene Polite Corley. Listen everywhere and watch on YouTube and Spotify.
Sports remains a profitable ad opportunity: Two-thirds of Americans are sports fans and over half have made a purchase based on audio ads.
The FTC’s challenge to Meta’s deals could fracture the social media giant's empire and signals that no acquisition, no matter its age, is safe from antitrust scrutiny.
Despite skyrocketing adoption and falling costs, most companies are stuck with small wins—highlighting a need for sharper, use-case-driven strategies.
As AI agents take over the grunt work, coders can step into roles that look more like architects and less like keyboard jockeys.
Novartis is the latest Big Pharma company to invest billions in US production capacity: The largest drugmakers continue moving manufacturing to the US as the industry awaits Trump’s tariff plan for pharma. Generic drugmakers—which supply 90% of US prescriptions—won’t have the same maneuverability.
Physicians aren’t burning out at the same rate as the COVID years: While doctor burnout rates are improving, it’s likely not enough progress to significantly impact turnover rates, and expense, to the healthcare system.
Online health information drives consumer decision-making: It’s an opportunity for healthcare and pharma brands and marketers to turn consumers into customers—and patients.
Tariffs may reduce US social media ad spend by $10 billion in 2025, or 10% versus our existing forecast.
Marketing hiring surge may be short lived: Listings increased 9.1% in Q1, but economic volatility raises questions about the industry’s resilience.
Consumers’ relatively stable financial footing could be undercut by trade war volatility. Already-tight lending standards could lead to a double-whammy for issuers.
BeReal launches its US ad business: The platform is looking to capitalize on TikTok’s uncertain future in the US.
They’re already skeptical of big financial players and would rather keep their data under lock and key.
UK regulators approve Shein IPO in a victory for China: While it may be too late for the fast-fashion retailer, the move could put the UK in China’s good graces and protect it from the worst of the trade war.
Budgeting concerns, high interest rates, and other factors are pushing the generation to alternatives.